Back
Berkshire Hathaway Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
45
BRK.B
Berkshire Hathaway
Last Price:
455.66
Seasonality Move:
3.41%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
273.83
Seasonality Move:
5.61%
Sell
45
Berkshire Hathaway (BRK.B)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
- The current Berkshire Hathaway [BRK.B] share price is $459.71. The Score for BRK.B is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BRK.B is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $276.33. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.B Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $459.71
The current trend is moderately bullish and BRK.B is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $276.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
BRK.B Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.26 | Buy |
| Relative Strength Index (14 RSI): | 56.97 | Buy |
| Chaikin Money Flow: | -15679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (447.36 - 467.04) | Buy |
| Bollinger Bands (100): | (405.54 - 448.04) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 60.54 | Buy |
| Chaikin Money Flow: | -66637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.89 - 278.47) | Buy |
| Bollinger Bands (100): | (164.63 - 269.71) | Buy |
BRK.B Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 454.41 | Buy |
| 20-day SMA: | 460.05 | Sell |
| 50-day SMA: | 444.96 | Buy |
| 200-day SMA: | 408.14 | Buy |
| 8-day EMA: | 456.63 | Buy |
| 20-day EMA: | 455.49 | Buy |
| 50-day EMA: | 445.16 | Buy |
| 200-day EMA: | 410.99 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 267.42 | Buy |
| 20-day SMA: | 266.35 | Buy |
| 50-day SMA: | 259.79 | Buy |
| 200-day SMA: | 191.66 | Buy |
| 8-day EMA: | 269.14 | Buy |
| 20-day EMA: | 265.86 | Buy |
| 50-day EMA: | 253.52 | Buy |
| 200-day EMA: | 208.02 | Buy |
Berkshire Hathaway Earnings Growth & BRK.B Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.70 per share, a decrease next quarter of $0.21 per share, an increase this year of $3.19 per share, and a decrease next year of $0.29 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Berkshire Hathaway Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||